Description: Adjuvants are included in sub-unit or recombinant vaccines to enhance the potency of poorly immunogenic antigens. Adjuvant discovery is as complex as it is a multidiscplinary intersection of formulation science, immunology, toxicology, and biology.
Description: Discovery is a range of technically innovative adjuvants, fertilisers and biostimulants. Each of our products undergoes a comprehensive R&D programme, screened for biological efficacy and supported by high quality trials conducted by:
Description: Send a contract proposal for funds to identify novel adjuvant candidates that can augment the efficacy of human vaccines, in response to NIAID’s recently issued broad agency announcement (BAA) Vaccine Adjuvant Discovery Program. The Science. This BAA supports developing new vaccine adjuvants that do the following:
Description: DISCOVERY ® adjuvants have the ability to maximise crop yields, significantly increase application productivity and reduce risks in adverse conditions. DISCOVERY ® adjuvants range brings the latest innovation in crop protection technologies and addresses spray improvements needs. in important crops and situations
Description: Adjuvant Development Program. ... Efforts to develop safe and effective vaccines increasingly involve the use of adjuvants — substances formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvant discovery and development play critical roles in NIAID vaccine development efforts.
Description: The need for new adjuvants is absolutely cardinal to the development of new vaccines and to further optimizing current immunization approaches. However, only a few classes of adjuvants are presently incorporated in vaccines approved for human use. Recent advances in the discovery and delivery of TLR agonists as vaccine adjuvants have begun to open up a new toolbox for vaccinologists. At the ...
Description: Peptide-based subunit vaccines are of great interest in modern immunotherapy as they are safe, easy to produce and well defined. However, peptide antigens produce a relatively weak immune response, and thus require the use of immunostimulants (adjuvants) for optimal efficacy.
Description: HIGH EFFICIENCY AND YIELD RESPONSE TO DISCOVERY® ADJUVANTS IN UKRAINE In 2016, the first year breakthrough performance DISCOVERY® adjuvants sales in Ukraine, Agrinova Solutions, LLC as an importer and distributor has arranged a range of field trials as per EPPO standards.
Description: The discovery also pharmacologically recontextualizes lipophilic statins and bisphosphonates as well as the MVA pathway itself and presents a new approach for the development of both vaccine adjuvants and cancer immunotherapies.
Description: NIAID adjuvant discovery contracts awarded in 2003 and 2009 identified adjuvants that trigger a small set of receptors of the innate, or inborn, immune system. The innate immune response helps shape adaptive, or acquired, immunity, which confers long-term protection from infection by specific pathogens.
Copyright © 2017